Replies to post #130176 on Biotech Values

[DewDiligence]

SNY’s Aubagio (teriflunomide) for MS accepted for review by EMA:

http://finance.yahoo.com/news/Genzyme-Announces-EMA-Accepts-bw-381928498.html?x=0

In the US, Aubagio has a PDUFA date in Jun 2012 (#msg-68164569).